🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A study to evaluate the efficacy, safety and tolerability of Remibrutinib v...
Status
Recruiting
Location
Neuromuscular Research Center
Start Date
2025-02-07
Trial ID
NCT06744920
Treatments Being Tested
This study is a Phase III, double-masked, multicenter, randomized, sham inj...
Status
Completed
Location
Multiple Locations
Start Date
2007-06
Trial ID
NCT00473382
Treatments Being Tested
This is a phase 3 clinical study conducted in China. The primary objective ...
Status
Not Yet Recruiting
Location
China-Japan Friendship Hospital
Start Date
2026-08-31
Trial ID
NCT07719023
Treatments Being Tested
This study will assess the saftey of giving fluticasone furoate 200mcg/GW64...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-11-18
Trial ID
NCT01266980
Treatments Being Tested
This study is evaluating the safety, effectiveness, and how the body absorb...
Status
Active Not Recruiting
Location
University of Minnesota
Start Date
2025-07-09
Trial ID
NCT06892288
Treatments Being Tested
The antifungal efficacy and safety of Jublia® topical solution will be asse...
Status
Completed
Location
Konkuk University Medical Center
Start Date
2017-11-10
Trial ID
NCT03280927
Treatments Being Tested
The purpose of this study is to evaluate the safety and preliminary efficac...
Status
Completed
Location
The Spine Institute
Start Date
2009-09
Trial ID
NCT00996073
This multi-center, randomized, double-blinded, placebo-controlled, dose-ran...
Status
Completed
Location
Praxis Research Site
Start Date
2021-10-14
Trial ID
NCT05021991
Treatments Being Tested
In this study, the efficacy and safety of two nilotinib doses, 300 mg twice...
Status
Completed
Location
University of California at Los Angeles Dept. of Hematology Clinic
Start Date
2007-07-31
Trial ID
NCT00471497
Phase 2 open label, randomized, active controlled, dose-ranging trial in ad...
Status
Recruiting
Location
Sierra Eye Associates
Start Date
2025-03-18
Trial ID
NCT06942520
Treatments Being Tested